bcbs texas glp 1 coverage Blue Cross Blue Shield to stop covering popular weight-loss drugs Blue Cross Blue Shield plans

4

Pancreatitis history History of pancreatitis: GLP-1 medications have been linked to a small but increased risk of pancreatitis, an inflammation of the pancreas

Routine monitoring of serum calcitonin or using thyroid ultrasound is of uncertain value for early detection of MTC in patients treated with (MOUNJARO OR ZEPBOUND) [see Contraindications (4) and Warnings and Precautions (5.1)]. Trulicity has the following boxed warning (2025) (formerly known as a black box warning), related to dulaglutide the main ingredient in Trulicity, set forth below: WARNING: RISK OF THYROID C-CELL TUMORS In male and female rats, dulaglutide causes a dose-related and treatment-duration-dependent increase in the incidence of thyroid C-cell tumors (adenomas and carcinomas) after lifetime exposure

Peptides like PT-141 act directly on the central nervous system to activate the pathways responsible for sexual desire